Insider trading

Period: 120 months Stock: STAA Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

63 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

63 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

63 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

63 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
63 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
63 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

63 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
17 Mar 2023
Holliday Keith Chief Technology Officer
Sold, plan not stated
$51.00K 823 at 61.97
2.9%
27 Sep 2022
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated 3×
$2.66M 35,425 at 75.00
50.4%
Sold half or more
15 Aug 2022
Holliday Keith Chief Technology Officer
Sold, plan not stated 2×
$1.76M 16,582 at 106.29
46.0%
21 Mar 2022
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$68.80K 922 at 74.62
1.6%
14 Mar 2022
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$18.55K 289 at 64.18
0.5%
14 Dec 2021
Holliday Keith Chief Technology Officer
Sold, plan not stated
$537.42K 6,000 at 89.57
26.4%
4 Oct 2021
Gesten Samuel J Chief Legal Officer
Sold, plan not stated
$1.72M 15,000 at 114.53
35.2%
7 Sep 2021
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated 2×
$6.40M 40,653 at 157.40
34.5%
2 Sep 2021
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated 2×
$4.47M 28,381 at 157.50
24.2%
1 Sep 2021
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated 2×
$4.13M 26,194 at 157.61
20.8%
18 Aug 2021
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$2.20M 15,000 at 146.91
22.2%
12 Aug 2021
Gesten Samuel J Chief Legal Officer
Sold, plan not stated
$4.00M 29,682 at 134.71
41.1%
24 May 2021
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated
$12.37M 94,855 at 130.42
46.7%
24 May 2021
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$1.89M 14,500 at 130.42
21.6%
21 May 2021
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$1.94M 15,261 at 126.83
22.5%
21 May 2021
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated
$658.56K 5,145 at 128.00
4.5%
12 May 2021
Hansen Graydon C. Sr. VP, Global Operations
Sold, plan not stated
$612.50K 5,531 at 110.74
38.5%
11 May 2021
Hansen Graydon C. Sr. VP, Global Operations
Sold, plan not stated
$1.24M 11,075 at 111.61
43.5%
10 May 2021
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated 2×
$1.50M 12,109 at 124.25
59.2%
Sold half or more
10 May 2021
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$1.46M 11,583 at 125.72
18.0%
10 May 2021
Holliday Keith Chief Technology Officer
Sold, plan not stated
$1.12M 8,874 at 125.83
28.1%
22 Mar 2021
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated
$106.30K 1,103 at 96.37
10.2%
22 Mar 2021
Gesten Samuel J Chief Legal Officer
Sold, plan not stated
$99.45K 1,032 at 96.37
2.4%
22 Mar 2021
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$88.85K 922 at 96.37
1.7%
1 Mar 2021
Hansen Graydon C. Sr. VP, Global Operations
Sold, plan not stated 3×
$3.49M 33,790 at 103.33
70.2%
Sold half or more
1 Mar 2021
Holliday Keith Chief Technology Officer
Sold, plan not stated 2×
$1.99M 18,991 at 104.55
39.5%
1 Mar 2021
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated
$1.69M 16,000 at 105.43
59.7%
Sold half or more
23 Nov 2020
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$1.52M 18,959 at 80.13
27.0%
23 Nov 2020
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated 2×
$396.68K 4,774 at 83.09
4.2%
20 Nov 2020
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated
$223.16K 2,688 at 83.02
2.4%
19 Nov 2020
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated
$1.15M 14,007 at 82.03
10.9%
9 Nov 2020
Holliday Keith Chief Technology Officer
Sold, plan not stated
$1.93M 23,714 at 81.56
40.9%
9 Nov 2020
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated
$1.63M 20,000 at 81.34
64.9%
Sold half or more
15 Sep 2020
Holliday Keith Chief Technology Officer
Sold, plan not stated
$1.94M 36,326 at 53.33
65.3%
Sold half or more
14 Sep 2020
Holliday Keith Chief Technology Officer
Sold, plan not stated 2×
$1.90M 35,689 at 53.32
64.9%
Sold half or more
10 Aug 2020
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated
$2.13M 41,602 at 51.22
79.4%
Sold half or more
15 Jun 2020
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated
$1.73M 39,215 at 44.07
23.5%
10 Jun 2020
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated
$34.54K 785 at 44.00
0.6%
21 May 2020
Gesten Samuel J Chief Legal Officer
Sold, plan not stated
$7.70M 192,522 at 40.00
82.4%
Sold half or more
15 May 2020
Holliday Keith Chief Technology Officer
Sold, plan not stated
$942.25K 25,000 at 37.69
46.8%
11 May 2020
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated
$1.82M 46,563 at 39.11
81.2%
Sold half or more
11 May 2020
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$736.52K 18,856 at 39.06
29.8%
11 May 2020
Hansen Graydon C. Sr. VP, Global Operations
Sold, plan not stated 4×
$709.71K 18,189 at 39.02
53.2%
Sold half or more
23 Mar 2020
Hansen Graydon C. Sr. VP, Global Operations
Sold, plan not stated
$77.13K 2,813 at 27.42
12.6%
23 Mar 2020
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated
$75.47K 2,813 at 26.83
20.7%
23 Mar 2020
Gesten Samuel J Chief Legal Officer
Sold, plan not stated
$75.19K 2,742 at 27.42
6.2%
23 Mar 2020
Francese James E Sr. VP, Comm. Ops., NA, APAC
Sold, plan not stated
$60.23K 2,250 at 26.77
4.8%
5 Dec 2019
Hayashida Jon K. VP, Global Clinical, Medical
Sold, plan not stated 2×
$1.76M 47,408 at 37.20
88.4%
Sold half or more
4 Dec 2019
Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China
Sold, plan not stated 2×
$1.72M 45,000 at 38.15
26.6%
20 Nov 2019
Hansen Graydon C. Sr. VP, Global Operations
Sold, plan not stated
$598.25K 17,083 at 35.02
67.2%
Sold half or more
Showing 1–50 of 63. Page 1 of 2 Older →